Is Circulating Osteocalcin Related to Adipokines and Overweight/Obesity in Children and Adolescents?

Abstract

Background:

Osteocalcin (OC) has recently been described to be involved in the regulation of glucose and energy metabolism. We aimed to evaluate whether or not OC serum levels were related to parameters of overweight and serum adipokine levels of healthy children and adolescents in dependence on gender and pubertal stage.

Methods:

In a cross sectional study (Leipzig Schoolchildren Project) 497 healthy, caucasian children and adolescents of all pubertal stages were included. We measured anthropometric data height, weight, fat mass, waist-to-hip ratio, pubertal development and performed biochemical analyses of osteocalcin, leptin, adiponectin and resistin serum levels by immunoassay.

Results:

OC serum levels were associated with pubertal development achieving peak values at Tanner stage 3. There was no significant association of OC serum levels with overweight and obesity as measured by BMI and WHR. In addition, OC demonstrated no significant association with serum levels of leptin and adiponectin but a negative association with resistin in both genders independent of pubertal stages (r= − 0.329, p<0.0001).

Conclusion:

We conclude that there is no major relationship between OC and metabolism, but we can not exclude minor relations between OC and metabolism. The negative relationship with serum resistin levels might rather point to a link between OC and inflammatory states.

Key words

osteocalcin - children - overweight - adipokines - leptin - adiponectin

• References

• 1 van Summeren M, Braam L, Noirt F et al. Pronounced elevation of undercarboxylated osteocalcin in healthy children. Pediatr Res 2007; 61: 366-370
• 2 Lee NK, Sowa H, Hinoi E et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130: 456-469
• 3 Ducy P, Desbois C, Boyce B et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996; 382: 448-452
• 4 Ferron M, Hinoi E, Karsenty G et al. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008; 105: 5266-5270
• 5 Brandao FR, Vicente EJ, Daltro CH et al. Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus. Diabetes Res Clin Pract 2007; 78: 334-339
• 6 Reinehr T, Roth CL. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes (Lond) 2010; 34: 852-858
• 7 Reich A, Muller G, Gelbrich G et al. Obesity and blood pressure – results from the examination of 2 365 schoolchildren in Germany. Int J Obes Relat Metab Disord 2003; 27: 1459-1464
• 8 Kiess W, Gausche R, Keller A et al. Computer-guided population-based screening system for growth disorders (CrescNet) and on-line generation of normative data for growth and development. Horm Res 2001; 56 (Suppl. 01) 59-66
• 9 Kromeyer-Hauschild K, Wabitsch M, Kunze D et al. Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschrift Kinderheilkunde 2001; 149: 807-818
• 10 Kratzsch J, Berthold A, Lammert A et al. A rapid, quantitative immunofunctional assay for measuring human leptin. Horm Res 2002; 57: 127-132
• 11 Kratzsch J, Lammert A, Bottner A et al. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence. J Clin Endocrinol Metab 2002; 87: 4587-4594
• 12 Gundberg CM, Lian JB, Gallop PM. Measurements of gamma-carboxyglutamate and circulating osteocalcin in normal children and adults. Clin Chim Acta 1983; 128: 1-8
• 13 Yilmaz D, Ersoy B, Bilgin E et al. Bone mineral density in girls and boys at different pubertal stages: relation with gonadal steroids, bone formation markers, and growth parameters. J Bone Miner Metab 2005; 23: 476-482
• 14 Hui SL, Dimeglio LA, Longcope C et al. Difference in bone mass between black and white American children: attributable to body build, sex hormone levels, or bone turnover?. J Clin Endocrinol Metab 2003; 88: 642-649
• 15 Bini V, Igli Baroncelli G, Papi F et al. Relationships of serum leptin levels with biochemical markers of bone turnover and with growth factors in normal weight and overweight children. Horm Res 2004; 61: 170-175
• 16 Zamboni G, Soffiati M, Giavarina D et al. Mineral metabolism in obese children. Acta Paediatr Scand 1988; 77: 741-746
• 17 Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin – the classical, resistin – the controversical, adiponectin – the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005; 19: 525-546
• 18 Bottner A, Kratzsch J, Muller G et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004; 89: 4053-4061
• 19 Reid IR, Cornish J, Baldock PA. Nutrition-related peptides and bone homeostasis. J Bone Miner Res 2006; 21: 495-500
• 20 Goldstone AP, Mercer JG, Gunn I et al. Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett 1997; 415: 134-138
• 21 Azuma K, Katsukawa F, Oguchi S et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003; 11: 997-1001
• 22 Silha JV, Krsek M, Skrha JV et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003; 149: 331-335
• 23 Filkova M, Haluzik M, Gay S et al. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol 2009; 133: 157-170